Though aluminum is scientifically proven to be detrimental to human health, aluminum’s toxicity has largely been understated or outright ignored, even by agencies tasked with protecting the public’s health. These organizations, like the CDC and FDA, are well-aware of research published on the toxic properties of aluminum; yet, aluminum adjuvants are not only present in many vaccines, but are increasing in concentration.
The latest release of the Gardasil HPV vaccine, Gardasil 9, is one example of increasing quantities of aluminum adjuvants. Gardasil 9, which has been engineered to protect against 9 different types of HPV, now contains more than twice the amount of aluminum adjuvant as Gardasil’s original version. Even Gardasil manufacturer Merck’s own study of its original version revealed alarming statistics about serious adverse effects of the vaccine, including disabilities and precancerous lesions, while independent research has identified more than 22,000 adverse effects associated with the Gardasil vaccine. Gardasil 9 contains 500 mg of aluminum adjuvant, while Gardasil contains just 225 mg; considering Gardasil 9 is administered in 3 doses over the course of 3 years, this means that recipients will intramuscularly receive 1500 mg of aluminum throughout their Gardasil 9 administration.
Gardasil 9 was also approved by the FDA without a review from the Vaccines and Related Biological Products Advisory Committee, a committee specifically tasked with assessing potential risk factors of vaccines that are up for FDA approval. In its letter of explanation, the FDA stated that Gardasil 9 did not present the type of controversy or concern that would merit a review from the VRBPAC. However, it’s only up to the VRBPAC itself to determine if any concerns exist. Forbes has already reported that a study of Gardasil 9 involving 13,000 recipients resulted in 305 reports of serious adverse effects.
Research supported by the Children’s Safety Medical Research Institute has also revealed that the Gardasil vaccine is 2.5 times more likely to cause a serious adverse effect than cervical cancer, the threat Gardasil is intended to protect against.
Aluminum adjuvants remain present in a wide range of routinely administered vaccines, including tetanus, diphtheria, hepatitis, and pertussis vaccines; because no official threshold has been established for safe quantities of aluminum exposure, no plans are in the works to reduce these current concentrations of aluminum adjuvants. As researcher Christopher Exley points out in his paper, “Human Exposure to Aluminum,” in 1950 Americans were exposed to approximately 1 mg of aluminum per day. By 2050, it’s projected that our level of daily exposure will increase to 100 mg.
Direct links have also recently been demonstrated between aluminum and Alzheimer’s disease, a neurological disease which, like autism, has been rapidly increasing in recent decades. In 2010 there were 500,000 new cases of Alzheimer’s, and this number is increasing each year. By 2050, it’s expected there will be 1 million new cases of Alzheimer’s each year. While some cases of Alzheimer’s result from genetic dispositions, its rapidly increasing rates are best explained by exposures to toxic environmental elements, like aluminum, which we are exposed to in increasing amounts and via more diverse avenues.
Unfortunately, there’s little question that our exposure to aluminum is increasing, and that little is being done to reduce it. It seems it will be up to researchers and a conscientious public to begin to change views about this highly toxic element.